TipRanks
Go Ultimate55% OFF

SkinBioTherapeutics (SBTX) Revenue

SkinBioTherapeutics Revenue

SkinBioTherapeutics had a revenue of 2.17M in the quarter ending Dec 31, 2024, with -29.25%. This bring the company's revenue in the last twelve months to 5.23M, Increased 12.70%. In the fiscal year ending Jun 30, 2024, SkinBioTherapeutics had annual revenue of 4.64M with 283.63% growth.

Revenue (ttm)
5.23M
Revenue Growth
95.16%
P/S Ratio
2.93
Revenue/Employee
GBP 113,126
Employees
41
Market Cap
GBP 13.61M

Revenue Chart

SkinBioTherapeutics Revenue - Annual

01M2M3M4M5M74.76K132.06K1.21M4.64M20182018201920202021202220232024
Revenue History
Download to Excel
GB:SBTX revenue history
Fiscal End DateRevenueChangeGrowth
Jun 30, 20244.64M3.43M283.63%
Jun 30, 20231.21M1.08M815.51%
Jun 30, 2022132.06K57.30K76.64%
Jun 30, 202174.76K74.76K―
Jun 30, 20200.000.00―
Jun 30, 20190.000.00―
Jun 30, 20180.000.00―
Jun 30, 20180.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
GB:SBTX5.23M
GB:IMM0.00
GB:OPTI1.29M
GB:AREC-95.00K
GB:APTA1.54M
GB:OBI2.85M